U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Encapsulation of biological material

Patent 4352883 Issued on October 5, 1982. Estimated Expiration Date: Icon_subject October 5, 1999. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

3522346

3725113

3730841

3733205

3827565

3860490

Inventor

Assignee

Application

No. 06/024600 filed on 03/28/1979

US Classes:

435/178, Carrier is carbohydrate264/4, ENCAPSULATING NORMALLY LIQUID MATERIAL424/424, Membrane or diffusion barrier424/496, Containing natural gums/resins424/497, Containing solid synthetic polymers424/94.3, Stabilized enzymes or enzymes complexed with nonenzyme (e.g., liposomes, etc.)435/175, Multi-enzyme system435/182, Enzyme or microbial cell is entrapped within the carrier (e.g., gel, hollow fibre)435/382Method of culturing encapsulated cells

Examiners

Primary: Naff, David M.

Attorney, Agent or Firm

International Classes

A01N 1/02 (20060101)
A61K 35/12 (20060101)
A61F 2/02 (20060101)
A61K 9/16 (20060101)
A61K 39/44 (20060101)
A61K 9/50 (20060101)
A61L 27/36 (20060101)
A61L 27/00 (20060101)
A61L 27/20 (20060101)
B01J 13/04 (20060101)
B01J 13/16 (20060101)
B01J 13/06 (20060101)
B01J 13/08 (20060101)
B01J 13/14 (20060101)
C12N 11/00 (20060101)
C12N 11/04 (20060101)
C12N 5/06 (20060101)
C12N 5/00 (20060101)
A61K 38/00 (20060101)

Abstract

A core material such as living tissue, individual cells, hormones, enzymes or antibodies is encapsulated in a semipermeable membrane that is permeable to small molecules for contact with the core material but is impermeable to potentially deleterious large molecules. Encapsulation may be carried out by suspending the core material in an aqueous medium containing a water soluble gum that can be reversibly gelled, forming the suspension into droplets, contacting the droplets with a solution of multivalent cations to gel the droplets as discrete, shape-retaining, water insoluble temporary capsules and cross-linking a surface layer of the temporary capsules to produce a semipermeable membrane around the capsules. Optionally the gel within the membrane may be reliquified by removing multivalent cations from the gel.

Other References

  • Chang, T.M.S., Biomedical Applications of Immobilized Enzymes and Proteins, vol. I, Plenum Press, N.Y., 1977, (pp. 69-90 and 147-153)
  • Tze, et al., Implantable Artificial Endocrine Pancreas Unit Used to Restore Normoglycaemia in the Diabetic Rat, Nature, vol. 264, 1976, (pp. 466-467)
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
 
Sign InRegister
Username  
Password   
forgot password?